‘Fill the Shoes’
In the short-term, Collins will continue to advise and there are distinguished, proven leaders within the NIH who are equipped to fill the void until a new director is in place, Ellie Dehoney, vice president of policy and advocacy for Research!America, said. “The biggest concern is how any Administration could possibly fill the shoes of such an extraordinarily effective leader and advocate,” Dehoney wrote in an email.
Dehoney said she’s confident that the administration and Congress can successfully agree on solid leaders for both the NIH and the FDA. “The biggest obstacle is the plethora of other priorities confronting the Administration and Senate,” she said.
Read the full article: